What's new

Human medicines European public assessment report (EPAR): Azacitidine Mylan, azacitidine, Date of authorisation: 27/03/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Azacitidine Mylan, azacitidine, Date of authorisation: 27/03/2020, Revision: 9, Status: Authorised

Apr 8, 2025 - 13:28
 0
Human medicines European public assessment report (EPAR): Azacitidine Mylan, azacitidine, Date of authorisation: 27/03/2020, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Azacitidine Mylan, azacitidine, Date of authorisation: 27/03/2020, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

DHL Plans $2 Billion Investment to Grow Healthcare Logistics

Next Article

Ember: Global solar generation exceeds 2,000TWh in 2024

Related Posts

Human medicines European public assessment report (EPAR): Rezolsta, darunavir,cobicistat, Date of authorisation: 19/11/2014, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 14, 2025  0

Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation: 11/11/2016, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 1, 2025  0

Extensions of marketing authorisations: questions and answers

Extensions of marketing authorisations: questions and a...

Mar 25, 2025  0